Adriamycin pfs and Visual acuity reduced - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced is reported as a side effect among people who take Adriamycin pfs (doxorubicin hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Nitroglycerin, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Visual acuity reduced when taking Adriamycin pfs. It is created by eHealthMe based on reports of 6,484 people who have side effects when taking Adriamycin pfs from the FDA, and is updated regularly.

What is Adriamycin pfs?

Adriamycin pfs has active ingredients of doxorubicin hydrochloride. eHealthMe is studying from 6,495 Adriamycin pfs users. Check the latest studies of Adriamycin pfs.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 1,491 drugs and 1,887 conditions by eHealthMe. Check the latest studies of Visual acuity reduced.

On Aug, 11, 2026

6,484 people reported to have side effects when taking Adriamycin pfs.
Among them, 17 people (0.26%) have Visual acuity reduced.

Could Adriamycin pfs cause Visual acuity reduced?

Among these 17 people:

How long have people been on Adriamycin pfs when they have Visual acuity reduced? *

What is the gender of people who have Visual acuity reduced when taking Adriamycin pfs? *

female: 41.18 %
male: 58.82 %

What is the age of people who have Visual acuity reduced when taking Adriamycin pfs? *

What are other drugs people take besides Adriamycin pfs? *

What are other side effects people have besides Visual acuity reduced? *

Pain: 7 people, 41.18%
Sinusitis (inflammation of sinus): 6 people, 35.29%
Tooth Disorder (tooth disease): 6 people, 35.29%
Injury: 6 people, 35.29%
Pain In Jaw: 6 people, 35.29%
Skin Blushing/flushing (a sudden reddening of the face, neck): 6 people, 35.29%
Chest Pain: 6 people, 35.29%
Stress And Anxiety: 6 people, 35.29%
Joint Pain: 6 people, 35.29%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 29.41%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 11.76%
Nausea (feeling of having an urge to vomit): 1 person, 5.88%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.88%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.88%
Metastases To Bone (cancer spreads to bone): 1 person, 5.88%
Hodgkin's Lymphoma (cancer originating from white blood cells): 1 person, 5.88%
Chest Pain: 1 person, 5.88%
Breast Cancer Metastatic: 1 person, 5.88%
Breast Cancer: 1 person, 5.88%
Back Pain: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Adriamycin pfs and have Visual acuity reduced?

- Check whether Visual acuity reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Adriamycin pfs:

Adriamycin pfs (6,495 reports)

Browse all side effects of Adriamycin pfs:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual acuity reduced:

Visual acuity reduced (1,491 drugs)

Browse all the conditions that are associated with Visual acuity reduced:

Visual acuity reduced (1,887 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on doxorubicin hydrochloride (the active ingredients of Adriamycin pfs) and Adriamycin pfs (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.